AVEO Soars On Phase II Results Vs. Avastin; Hospira Issues Statement on FDA Approval of buy viagra in canada First Biosimilar in US

Print E-mail
By Josh Gee   
Friday, 06 March 2015 19:54
Below is a look at some of sildenafil citrate generic the buy priligy headlines for companies that made news in the generic cialis soft tabs healthcare sector on March 6, 2015.
Read more...
 

PlasmaTech Announces Initiation of prednisone online Enrollment of viagra fast delivery MuGard® Trial for Afinitor®; Ironwood Initiates Phase I Clinical Study of buying cialis online IW-1973

Print E-mail
By Mary Davila   
Thursday, 05 March 2015 20:08
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 5, 2015.
Read more...
 

Vanda Announces Tradipitant Phase II Proof of buy cialis without a prescription Concept Study Results for Chronic Pruritus; Aerpio Announces Publication of buy clomid online Positive Results of overnight canadian viagra Phase 1b/2a of AKB-9778

Print E-mail
By William Kent   
Wednesday, 04 March 2015 20:42
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 4, 2015.
Read more...
 

Adamis Announces Positive Results For Its Dry Powder Inhaler Product; Biota Commences Dosing in Vapendavir SPIRITUS Phase 2b Trial

Print E-mail
By Mary Davila   
Tuesday, 03 March 2015 19:11
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 3, 2015.
Read more...
 

Aldeyra Provides Update on NS2 Clinical Program; Acasti Receives Full Data for Phase II TRIFECTA Trial

Print E-mail
By Josh Gee   
Monday, 02 March 2015 19:49
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 2, 2015.
Read more...
 

Acasti Gains Ahead Of Expected Phase II Results; Cyberonics Plans To Merge With Milan's Sorin SpA

Print E-mail
By William Kent   
Thursday, 26 February 2015 20:15
Below is a look at some of the headlines for companies that made news in the healthcare sector on February 26, 2015.
Read more...
 

Gilead Reports Preclinical Data; Bristol-Myers Squibb Launches Phase III Trial Of buy antabuse HIV Drug

Print E-mail
By Josh Gee   
Wednesday, 25 February 2015 20:06
Below is a look at some of the headlines for companies that made news in the healthcare sector on February 25, 2015.
Read more...
 

FDA Approves the purchase real name brand viagra Medtronic's VenaSeal Closure System; Cytori Receives Positive European Opinion on Orphan Drug Status

Print E-mail
By Marilyn Mullen   
Tuesday, 24 February 2015 19:58
Below is a look at some of the headlines for companies that made news in the healthcare sector on February 24, 2015.
Read more...
 

FDA Grants Seven Years' Market Exclusivity to Eagle Pharmaceuticals' Ryanodex; Bristol-Myers Aquires Flexus Biosciences' Pipeline

Print E-mail
By Josh Gee   
Monday, 23 February 2015 19:31
Below is a look at some of the headlines for companies that made news in the healthcare sector on February 23, 2015.
Read more...
 

NW Biotherapeutics' Phase III Trial of DCVAX®-L for GBM Brain Cancer Approved to Proceed in Canada; FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf

Print E-mail
By Josh Gee   
Thursday, 19 February 2015 19:56
Below is a look at some of the headlines for companies that made news in the healthcare sector on February 19, 2015.
Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 356

Newsletter

BioMedReports AVEO Soars On Phase II Results Vs. Avastin; Hospira Issues Statement on FDA Approval of First Biosimilar in US... http://t.co/WKjVoqxoCl
29sreplyretweetfavorite
BioMedReports PlasmaTech Announces Initiation of Enrollment of MuGard® Trial for Afinitor®; Ironwood Initiates Phase I Clini... http://t.co/KyllsUrHGp
24hreplyretweetfavorite
BioMedReports Vanda Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus; Aerpio Announces Pub... http://t.co/IxLj84frcl